Exploring Lassa Virus Proteome to Design a Multi-epitope Vaccine Through Immunoinformatics and Immune Simulation...

Area of Science:

• Vaccinology
• Immunoinformatics
• Virology

Background:

• Lassa virus (LASV) causes Lassa fever, a severe hemorrhagic illness with high mortality.
• Limited effective treatments and preventive measures exist for Lassa fever in endemic areas.

Purpose of the Study:

• To design and evaluate a multi-epitope peptide-vaccine as a prophylactic agent against Lassa virus using immunoinformatics.
• To assess the vaccine's physicochemical properties, immunogenicity, safety, and potential efficacy.

Main Methods:

• Design of a multi-epitope vaccine incorporating T-cell and B-cell epitopes from LASV proteins.
• In silico assessment of vaccine physicochemical properties, stability (disulfide engineering), and binding affinity to TLR2 via molecular docking and dynamics.
• Immune simulation for cell-mediated immunity and antigen clearance, followed by codon optimization for expression in E. coli K12.

Main Results:

• A chimeric vaccine (~68 kDa) was constructed with T-cell (CTL, HTL) and B-cell epitopes, linkers, and an adjuvant.
• The vaccine demonstrated good physicochemical properties, stability, and binding efficiency with TLR2.
• In silico analysis predicted high worldwide population coverage (97.37%) for chosen epitopes, enhanced cell-mediated immunity, and rapid antigen clearance.

Conclusions:

• The designed multi-epitope peptide-vaccine is a promising candidate for Lassa fever prevention.
• Further in vitro and in vivo studies are warranted to validate its immunogenicity and efficacy as a potential immunogen against Lassa virus.